European Healthtech startup funding raised during September 2021.
In September 2021, 64 European Healthtech companies raised a combined €895M across 64 funding rounds, down 5.1% versus September 2020. UK led by capital raised, and Crista Galli Ventures was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Touchlight | Other | Sep 2021 | €107M |
| Oviva | Series C | Sep 2021 | €68M |
| TreeFrog Therapeutics | Series B | Sep 2021 | €64M |
| Kinarus | Other | Sep 2021 |
| Sep 2021 |
| €148M |
| Jour | Acquisition | Sep 2021 | €17M |
| €52M |
| Lifebit | Other | Sep 2021 | €51M |
| Anjarium Biosciences | Series A | Sep 2021 | €51M |
| Owlstone Medical | Series D+ | Sep 2021 | €49M |
| Flo Health | Series B | Sep 2021 | €42M |
| Flo | Series B | Sep 2021 | €42M |
| Exscientia | Other | Sep 2021 | €41M |
| Numan | Series B | Sep 2021 | €34M |
| Meru Health | Series B | Sep 2021 | €32M |
| Accurx | Series B | Sep 2021 | €32M |
| SmartCella | Other | Sep 2021 | €32M |
| Corti | Other | Sep 2021 | €23M |
